It has been demonstrated that the activation of the PI3-kinase pathway might enhance the invasive ability of tumor cells into lymph nodes and PIK3CA mutation is related with the loss of PTEN which inhibits cell migration [31]. This evidence concerns the gene PIK3CA and neoplasm.